This regular gathering of leaders at Milken Institute events will examine policy priorities and investments that will be required in the wake of the COVID-19 pandemic to accelerate biomedical innovation and address public health challenges. This off-the-record session allows participants—government leaders along with executives from business, academia, and nonprofits—to engage in an informative, candid dialogue.